BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19761433)

  • 21. Hypereosinophilic syndromes.
    Roufosse FE; Goldman M; Cogan E
    Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilic myeloid disorders.
    Noel P
    Semin Hematol; 2012 Apr; 49(2):120-7. PubMed ID: 22449622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophilic myeloid neoplasms.
    Noel P; Mesa RA
    Curr Opin Hematol; 2013 Mar; 20(2):157-62. PubMed ID: 23385615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel therapies for hypereosinophilic syndromes.
    Antoniu SA
    Neth J Med; 2010 Aug; 68(1):304-10. PubMed ID: 20739727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid neoplasms with eosinophilia.
    Reiter A; Gotlib J
    Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia].
    Chrobák L; Voglová J
    Vnitr Lek; 2005 Dec; 51(12):1385-93. PubMed ID: 16430106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical management of the hypereosinophilic syndromes.
    Cogan E; Roufosse F
    Expert Rev Hematol; 2012 Jun; 5(3):275-89; quiz 290. PubMed ID: 22780208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of idiopathic hypereosinophilic syndrome with imatinib].
    Sørensen AL; Larsen H
    Ugeskr Laeger; 2008 Jan; 170(4):254. PubMed ID: 18282461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypereosinophilic syndrome and proliferative diseases.
    Ionescu MA; Wang L; Janin A
    Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia.
    Curtis CE; Grand FH; Musto P; Clark A; Murphy J; Perla G; Minervini MM; Stewart J; Reiter A; Cross NC
    Br J Haematol; 2007 Jul; 138(1):77-81. PubMed ID: 17555450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophilia in Hematologic Disorders.
    Falchi L; Verstovsek S
    Immunol Allergy Clin North Am; 2015 Aug; 35(3):439-52. PubMed ID: 26209894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia.
    Kalac M; Quintás-Cardama A; Vrhovac R; Kantarjian H; Verstovsek S
    Cancer; 2007 Sep; 110(5):955-64. PubMed ID: 17654661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome.
    Griffin JH; Leung J; Bruner RJ; Caligiuri MA; Briesewitz R
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7830-5. PubMed ID: 12808148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eosinophilia: secondary, clonal and idiopathic.
    Tefferi A; Patnaik MM; Pardanani A
    Br J Haematol; 2006 Jun; 133(5):468-92. PubMed ID: 16681635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and therapeutic management in patients with hypereosinophilic syndromes.
    Helbig G; Kyrcz-Krzemień S
    Pol Arch Med Wewn; 2011; 121(1-2):44-52. PubMed ID: 21346698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Practical approach to hypereosinophilia].
    Roufosse F; Cogan E
    Rev Med Brux; 2008 Sep; 29(4):400-8. PubMed ID: 18949995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic eosinophilic leukemia/hypereosinophilic syndrome.
    Gotlib J
    Cancer Treat Res; 2008; 142():69-106. PubMed ID: 18283783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with imatinib in a patient with chronic eosinophilic leukemia not otherwise specified.
    Iurlo A; Fracchiolla NS; Ferla V; Cassin R; Gottardi E; Beghini A; Gianelli U; Spinelli O; Cortelezzi A
    J Clin Oncol; 2014 Apr; 32(10):e37-9. PubMed ID: 24449233
    [No Abstract]   [Full Text] [Related]  

  • 39. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of a case of pediatric hypereosinophilic syndrome with anti-interleukin-5.
    Mehr S; Rego S; Kakakios A; Kilham H; Kemp A
    J Pediatr; 2009 Aug; 155(2):289-91. PubMed ID: 19619754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.